6-K ·Filed Jun 2, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine IR engagement with no immediate catalyst. Monitor for future pipeline updates or financial disclosures that could move the stock.
Final — all horizons settled through T+60d ⚠ clustered
QNTM ▼ -39.92% at T+60d
NEUTRAL call -39.92% · α vs SPY -41.04% · entry $5.11 → $3.07
T+1d
-4.50%
call -4.50% · α -3.78%
$4.88
settled 5mo ago
T+5d
-23.87%
call -23.87% · α -20.91%
$3.89
settled 5mo ago
T+20d
-34.25%
call -34.25% · α -32.68%
$3.36
settled 4mo ago
T+60d
-39.92%
call -39.92% · α -41.04%
$3.07
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Quantum BioPharma engaged Stocks.news/IR Agency LLC for investor relations and marketing services for 6 months at a $250,000 fee. The filing is a routine service agreement with no financial or operational data, and no material impact on the company's fundamentals or pipeline.
Key Facts
- Quantum BioPharma entered an IR and consulting agreement with Stocks.news via IR Agency LLC starting June 8, 2026.
- The agreement is for 6 months at a fee of US$250,000.
- The Agency and its principals hold no equity interest in Quantum's securities.
- Rafael Pereira will provide the investor relations services.
- No financial results, pipeline updates, or operational changes were disclosed.
Financial Impact
US$250,000 fee for 6 months of IR services; no revenue or earnings impact disclosed.
Risk Factors
- The $250,000 fee is a cash expense for a company with a $34M market cap, but no material financial impact is indicated.
- No guarantee that the IR campaign will increase investor awareness or share price.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003862 |
| Document: f6k_060226.htm | 0001171843-26-003862 |
| Document: 0001171843-26-003862-index-headers.html | 0001171843-26-003862 |
| Document: 0001171843-26-003862.txt | 0001171843-26-003862 |
30 reports for QNTM
44% Hit rate @ T+20 Went positive at some point 6 of 9 best @ T+1▲ +52.58%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.11 | awaiting T+20 | — | $2.24 (−27.97%) |
Oct 6, 2026 20d ago | 6-K | $3.09 | awaiting T+20 | — | $2.24 (−27.51%) |
Oct 6, 2026 20d ago | Press Release | $3.09 | awaiting T+20 | — | $2.24 (−27.51%) |
Oct 5, 2026 21d ago | SC 13G/A | $3.27 | awaiting T+20 | — | $2.24 (−31.50%) |
Sep 24, 2026 4w ago | 6-K | $4.00 $2.27 | ▼ −43.25% | ▼ −42.83% | $2.24 (−44.00%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.24 (−39.78%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.24 (−39.78%) |
Sep 15, 2026 5w ago | 6-K | $3.46 $2.89 | ▼ −16.47% | ▼ −19.45% | $2.24 (−35.26%) |
Sep 1, 2026 7w ago | 6-K | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.24 (−27.27%) |
Sep 1, 2026 7w ago | Press Release | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.24 (−27.27%) |
Showing 10 of 30
US Market Status
Market Closed — Opens Wed (12h 42m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers